The results suggest that CYPA is involved in drug resistance in ovarian cancer, Treatment with synergistic combinations of (CS and ART using 4/0 h), (CS and OA using 0/4 h) (CS and ART using 0/0 h) partially restored CYPA expression. Here, PPIA is linked to ovarian carcinoma.